Merck pauses Keytruda studies to assess patient deaths

13th June 2017 Uncategorised 0

Merck has paused new enrolment in two studies assessing its immunotherapy Keytruda treatment in combination with other therapies in multiple myeloma to address safety concerns.

More: Merck pauses Keytruda studies to assess patient deaths
Source: News